VITREO RETINAL TECHNOLOGIES IN has a total of 29 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, China and Brazil. Its main competitors in its focus markets pharmaceuticals and machines are PARSROOS CO, ALSGEN INC and INNOVATIVE DRUG DELIVERY SYSTE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | China | 4 | |
#3 | Brazil | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Israel | 3 | |
#6 | Mexico | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | New Zealand | 2 | |
#9 | Australia | 1 | |
#10 | Bulgaria | 1 | |
#11 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Castillejos David | 19 |
#2 | Park John | 10 |
#3 | Karageozian Vicken | 7 |
#4 | Karageozian Vicken H | 5 |
#5 | John Park | 4 |
#6 | Aragon Gabriel Arthuro Carpio | 4 |
#7 | Flores Jose Luis Gutierres | 4 |
#8 | David Castillejos | 3 |
#9 | Arthuro Carpio Aragon Gabriel | 1 |
#10 | Gutierres Floress Jose Luis | 1 |
Publication | Filing date | Title |
---|---|---|
US2005137124A1 | Agents for intravitreal administration to treat or prevent disorders of the eye | |
MXPA04008776A | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye. | |
IL163938D0 | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye | |
US2003199574A1 | Treatment of ophthalmic disorders using urea and urea derivatives | |
BR0307611A | Methods of treating an ophthalmic disorder, preventing or treating a nerve disorder, and using a compound | |
US7008960B1 | Agents for intravitreal administration to treat or prevent disorders of the eye | |
WO0051620A1 | Agents for intravitreal administration to treat or prevent disorders of the eye | |
US6462071B1 | Agents for intravitreal administration to treat or prevent disorders of the eye |